The aim of the In-Vivo Functional Onco-lmaging (IVFOI) Shared Resource (SR) is to enhance and support basic and clinical cancer researchers by providing them with the necessary expertise, imaging instrumentation, and image analysis techniques. The major achievements during this funding cycle are: 1) establishing several multi-modality imaging systems to support innovative imaging studies;and 2) providing high-quality image acquisition and data analysis services for translational clinical studies. In the next cycle we will continue to develop along these areas to support various scientific needs of the investigators at the Chao Family Comprehensive Cancer Center (CFCCC) in performing in-vivo imaging studies. The current available systems include three MRI scanners (3T- human, 4T- human and animal, and 7Tanimal), and a combined MRI-DOT (diffuse optical tomography) system for both animal and human. The 4T MRI scanner provides an open architecture for development of new imaging methods, as well as for integration of the second modality such as DOT to form a combined system. A 2D Fluorescence &X-ray system currently being used by some Cancer Center Members will be managed by IVFOI. A prototype 3-D fluorescence &bioluminescence tomography system integrated with a micro CT has been built. These systems will support various needs of CFCCC Members in designing innovative imaging components into their studies, providing anatomical and functional information. The Shared Resource will also support translational clinical studies, with a precise protocol execution and a high standard quality control. The SR has been supporting the collection of more than 900 breast MRI studies with unified protocols, and as such a large database has been collected. In the next cycle we will continue to support such clinical studies, and also to support translational clinical research using the developed multi-modality imaging system, such as to evaluate the diagnostic performance of the combined MRI-DOT system for breast cancer. Overall, the IVFOI will provide CFCCC Members with ready access to state-of-the-art technologies, consultation for design of experiments and imaging protocols, and image acquisition and data analysis, as well as coordination among individual projects. Through the sharing of imaging and analysis protocol, we will be able to integrate various information obtained from different projects to facilitate future collaboration between CFCCC Members and to bring together basic scientists and clinical researchers to design and conduct clinical translational studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA062203-18
Application #
8740840
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-09-11
Project End
2014-01-31
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
18
Fiscal Year
2013
Total Cost
$18,338
Indirect Cost
$6,653
Name
University of California Irvine
Department
Type
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92697
Charney, Rebekah M; Forouzmand, Elmira; Cho, Jin Sun et al. (2017) Foxh1 Occupies cis-Regulatory Modules Prior to Dynamic Transcription Factor Interactions Controlling the Mesendoderm Gene Program. Dev Cell 40:595-607.e4
HD iPSC Consortium (2017) Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice. Nat Neurosci 20:648-660
McCracken, A N; McMonigle, R J; Tessier, J et al. (2017) Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation. Leukemia 31:669-677
Barton, James C; Chen, Wen-Pin; Emond, Mary J et al. (2017) GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes. Blood Cells Mol Dis 63:15-20
Yan, Huaming; Romero-Lopez, Monica; Frieboes, Hermann B et al. (2017) Multiscale Modeling of Glioblastoma Suggests that the Partial Disruption of Vessel/Cancer Stem Cell Crosstalk Can Promote Tumor Regression Without Increasing Invasiveness. IEEE Trans Biomed Eng 64:538-548
Klempner, Samuel J; Mehta, Pareen; Schrock, Alexa B et al. (2017) Cis-oriented solvent-front EGFR G796S mutation in tissue and ctDNA in a patient progressing on osimertinib: a case report and review of the literature. Lung Cancer (Auckl) 8:241-247
Molino, Nicholas M; Neek, Medea; Tucker, Jo Anne et al. (2017) Display of DNA on Nanoparticles for Targeting Antigen Presenting Cells. ACS Biomater Sci Eng 3:496-501
Lomeli, Naomi; Di, Kaijun; Czerniawski, Jennifer et al. (2017) Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats. Free Radic Biol Med 102:274-286
Huang, Jason Y; Samarasena, Jason B; Tsujino, Takeshi et al. (2017) EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study. Gastrointest Endosc 85:996-1001
Elbir, Haitham; Sitlani, Parth; Bergström, Sven et al. (2017) Chromosome and Megaplasmid Sequences of Borrelia anserina (Sakharoff 1891), the Agent of Avian Spirochetosis and Type Species of the Genus. Genome Announc 5:

Showing the most recent 10 out of 1031 publications